Compare IDEXX Laboratories, Inc. (IDXX) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs ON Holding AG — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while ON Holding AG trades at $35.09 (market cap $11.38B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.6× ON Holding AG's market cap, and ON Holding AG is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and ON Holding AG for 22 Days on average.
| IDXX | ONON | |
|---|---|---|
Market Cap | $40.43B | $11.38B |
Volume | 692,164 | 13,732,872 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $50.63 |
52-Week Low | $504.70 | $26.76 |
Typical Hold Time | 46 Days | 22 Days |
Enterprise Value | $41.32B | $10.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
ONON trades at $34.04, up 2.47% today, with a bullish technical signal from moving averages but overbought oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.44 exceeding the $0.4203 estimate. Revenue reached $3.01B in 2025, with net income of $203.70M, and profitability metrics like a 64.82% gross margin and 23.95% ROE indicate operational strength. Recent news highlights a $1 billion share buyback plan and ambitious 2029 targets.
The outlook is positive, supported by analyst consensus with a $42.26 price target and 74% buy ratings. Key opportunities include direct-to-consumer growth and expansion into new sports categories, while risks involve competitive pressures and execution of long-term goals amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
